Privia Health (PRVA) EBIT (2020 - 2026)

Privia Health has reported EBIT for 7 years, with the latest figure at $7.4 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 42.24% year-over-year to $7.4 million; the trailing twelve-month figure through Mar 2026 stood at $36.4 million (up 70.46% YoY), and the FY2025 full-year result was $34.2 million, up 101.6% from the prior year.
• EBIT for Q1 2026 stood at $7.4 million, down from $11.3 million in the prior quarter.
• The five-year high for EBIT was $14.4 million in Q3 2025, with the low at -$11.5 million in Q1 2022.
• Average EBIT over 5 years is $3.5 million, with a median of $5.2 million recorded in 2025.
• Year-over-year, EBIT sank 246.04% in 2022 and soared 534.02% in 2025.
• Tracing PRVA's EBIT over 5 years: stood at $2.2 million in 2022, then tumbled by 36.86% to $1.4 million in 2023, then soared by 269.58% to $5.2 million in 2024, then surged by 114.9% to $11.3 million in 2025, then sank by 34.19% to $7.4 million in 2026.
• The last three EBIT figures came in at $7.4 million (Q1 2026), $11.3 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.

Peer Comparison